← All companies

TRXB

TRex Bio, Inc.

TRXB Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$15.50

+0.26 +1.71%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$13.21 – $16.56

Recent SEC filings

38 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws Oct 13, 2026

Other filings

SCHEDULE 13G Oct 16, 2026

SCHEDULE 13D Oct 16, 2026

SCHEDULE 13D Oct 16, 2026

4 FORM 4 Oct 15, 2026

SCHEDULE 13G Oct 15, 2026

4 FORM 4 Oct 13, 2026

S-8 Oct 9, 2026

424B4 Oct 9, 2026

3 FORM 3 Oct 8, 2026

3 FORM 3 Oct 8, 2026

3 FORM 3 Oct 8, 2026

EFFECT Oct 8, 2026

CERT Oct 8, 2026

8-A12B Oct 6, 2026

S-1/A Oct 5, 2026

S-1 Sep 18, 2026

DRS/A Aug 21, 2026

DRS/A Jul 31, 2026

DRS Jun 26, 2026